Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes
BackgroundSomatostatin receptors (SSTR) and chemokine receptor CXCR4 are expressed in lymphomas, while the abundance is known to be heterogeneous in different subtypes of lymphomas. Targeting tumor cells expressing these receptors might add to therapeutic opportunities while radiolabeled ligands for...
Main Authors: | Tiina Juntikka, Samuli Vaittinen, Tero Vahlberg, Sirkku Jyrkkiö, Heikki Minn |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.710900/full |
Similar Items
-
Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
by: Daniel Kaemmerer, et al.
Published: (2017-12-01) -
SOMATOSTATIN RECEPTORS AS POTENTIALTHERAPEUTIC TARGETS IN THE TREATMENT OF ADVANCED ADRENOCORTICAL CANCER. A CASE REPORT
by: A. A. Kolomeytseva, et al.
Published: (2018-05-01) -
Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies
by: Czajkowski, M., et al.
Published: (2022) -
Somatostatin Serves a Modulatory Role in the Mouse Olfactory Bulb: Neuroanatomical and Behavioral Evidence
by: Sonia Nocera, et al.
Published: (2019-04-01) -
Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
by: Wei Wu, et al.
Published: (2020-09-01)